Novo Nordisk's Wegovy Pill Now Available in Pharmacies: A New Development in the Weight-Loss Competition.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Should l Buy FDS?
Source: Barron's
Launch of Wegovy Pill: Novo Nordisk has introduced a pill version of its weight-loss drug Wegovy, expanding its product offerings in the weight-loss market.
Pricing Strategy: The starter dose of the Wegovy pill is priced at $149 per month for customers paying out of pocket, positioning it competitively in the growing weight-loss drug sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FDS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FDS
Wall Street analysts forecast FDS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FDS is 295.91 USD with a low forecast of 253.00 USD and a high forecast of 326.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
1 Buy
7 Hold
4 Sell
Hold
Current: 225.430
Low
253.00
Averages
295.91
High
326.00
Current: 225.430
Low
253.00
Averages
295.91
High
326.00
About FDS
FactSet Research Systems Inc. is a global financial digital platform and enterprise solutions provider. The Company's solutions deliver financial data, analytics, and open technology to global clients, including individual users. Its segments include the Americas, EMEA and Asia Pacific. It provides financial data and market intelligence on securities, companies, industries and people to enable its clients to research investment ideas and analyze, monitor and manage their portfolios. It supports various workflows, including investment research, quantitative research, portfolio management and trading, portfolio analytics, wealth management, ESG investing solutions, industry analysis and data solutions. It provides open and flexible technology offerings, including a configurable desktop and mobile platform, and comprehensive data feeds. Its technology also includes LogoIntern, a workflow tool to streamline the task of adding, organizing, and formatting logos into pitch decks.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Amazon Earnings Miss: Amazon reported fourth-quarter earnings of $1.95 per share, falling short of the $1.97 consensus estimate, resulting in a 9% drop in shares, highlighting pressures in the competitive e-commerce landscape.
- Reddit Stock Surge: Reddit's stock rose 4% after its fourth-quarter earnings exceeded expectations, coupled with a $1 billion share buyback program, which is expected to boost investor confidence and enhance future shareholder returns.
- Molina Healthcare Loss: Molina Healthcare posted an adjusted loss of $2.75 per share, leading to a 33% decline in shares, primarily due to pressures from Medicaid premium adjustments and Medicare costs, with full-year revenue projected at $44.5 billion, below the $46.55 billion forecasted by analysts.
- Envista Strong Performance: Envista reported fourth-quarter earnings of 38 cents per share and revenue of $750.6 million, resulting in a 14% increase in shares, with expectations of 2% to 4% core sales growth in 2026, indicating robust performance in the dental products market.
See More
- McKesson Earnings Beat: McKesson's fiscal third-quarter earnings per share exceeded Wall Street's highest estimates, and the adjusted full-year EPS guidance was raised above analyst consensus, leading to a 16% stock price increase, indicating strong performance in the medical supply sector.
- Bob's Discount Furniture IPO: Bob's Discount Furniture debuted on the New York Stock Exchange with shares priced at $17, recently rising 10%, marking a successful entry into the public market and laying the groundwork for future growth.
- Fluence Energy Earnings Miss: Fluence Energy reported first-quarter revenue of $475.2 million, falling short of the $481.2 million consensus, with a per-share loss of 34 cents missing the 21-cent loss estimate, resulting in a 31% stock price drop, reflecting market concerns over its profitability.
- Cardinal Health Guidance Raised: Cardinal Health reported quarterly adjusted earnings of $2.63 per share, exceeding the $2.36 consensus, with revenue of $65.63 billion surpassing the $64.14 billion estimate, leading to an 8% stock price increase, showcasing strong growth potential in the healthcare services sector.
See More
- Weak Economic Growth: The real GDP growth for the first three quarters of 2025 was only 2.51%, falling short of the 10-year (2.75%), 30-year (2.58%), and 50-year (2.84%) averages, indicating that Trump's tariff policies have failed to effectively stimulate the economy and may lead to future market declines.
- AI Support: According to the Federal Reserve Bank of St. Louis, AI spending contributed 0.97 percentage points to GDP growth in the first nine months of 2025, suggesting that without this investment, GDP growth would have been merely 1.54%, highlighting the economy's reliance on technological advancements rather than tariff policies.
- Valuation Risks: The S&P 500 currently trades at a forward P/E ratio of 22.2, a level only sustained during the dot-com bubble and the COVID-19 pandemic, indicating that if companies fail to meet high expectations, a significant market downturn could occur.
- Midterm Election Uncertainty: Historical data shows that the S&P 500 experiences a median intra-year drawdown of 19% during midterm election years, suggesting that in 2026, the market faces multiple pressures from high valuations, tariffs, and political uncertainty, raising the risk of a bear market.
See More
- Economic Growth Stagnation: Despite Trump's claims that tariffs have bolstered economic growth, GDP growth was actually below average during the first three quarters of 2025, indicating that tariff policies have not delivered the expected economic boost.
- Valuation Risks: The S&P 500's forward price-to-earnings ratio stands at 22.2, a level historically sustained only during the dot-com bubble and the COVID-19 pandemic, suggesting a heightened risk of an impending bear market.
- Midterm Election Uncertainty: The S&P 500 has experienced a median intra-year drawdown of 19% during midterm election years, indicating that the market may face significant downward pressure in 2026 due to policy uncertainty.
- Investor Opportunities: Despite the challenges posed by high valuations and tariffs, historical data shows that every market drawdown has presented buying opportunities, suggesting that future market corrections could again serve as advantageous entry points for investors.
See More
- Tech Sector Performance: The tech sector continues to experience a downturn, marking the second consecutive day of losses.
- Earnings Reports: Despite the slump, most earnings reports released today were solid, though they were insufficient to reverse the negative trend.
See More
- Earnings Report: Golub Capital BDC reported adjusted earnings of $0.25 per share for fiscal Q1, reflecting the company's stable performance in the current economic environment despite market volatility.
- Earnings Stability: The earnings per share matched market expectations, indicating the company's continued profitability in the credit investment sector, even amid overall market uncertainty.
- Portfolio Performance: The stability of Golub Capital BDC's investment portfolio in Q1 suggests effective risk management under its diversified investment strategy, potentially laying the groundwork for future earnings growth.
- Market Reaction: Although the earnings report did not significantly exceed expectations, the market's neutral response to the company's stable financial performance reflects cautious optimism among investors regarding its future growth potential.
See More











